Mohamed Mahmoud Nabeel

Learn More
BACKGROUND In the Barcelona Clinic Liver Cancer (BCLC) system, only sorafenib is suggested for HCC patients having performance status (PS) 1 or 2 even if they have treatable lesions. In the current(More)
BACKGROUND Hepatocellular carcinoma is a leading cause of cancer-related death in Africa, but there is still no comprehensive description of the current status of its epidemiology in Africa. We(More)
  • Mohamed El Kassas, Dalia Abd El Hamid Omran, +11 authors Gamal Esmat
  • Journal of interferon & cytokine research : the…
  • 2018
The aim of this study was to retrospectively analyze the outcome of an unscheduled change in national Egyptian policies for the treatment of hepatitis C virus (HCV), which was transpired as a result(More)
  • 1